Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:U46619
go back to main search page
Accession:XCO:0000796 term browser browse the term
Definition:A prostaglandin endoperoxide analogue (11,9 epoxymethano-prostaglandin H2) that is a selective agonist of prostaglandin H2 (PGH2)/thromboxane A2 (TxA2) (TP) receptor. It is a stable thromboxane A2 mimetic and a vasoconstrictor.
Synonyms:exact_synonym: 9,11-Dideoxy-9α,11α-methanoepoxyprostaglandin F 2α;   U 46619
 xref: CAS:56985-40-1;   PMID:22508433



show annotations for term's descendants           Sort by:

Related Phenotype Data for Term "U46619" (XCO:0000796)

Rat Strains:
Clinical Measurements:
Experimental Conditions:
Measurement Methods:

Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    chemical 1266
      chemical with specified function 517
        activator 1
          receptor agonist 1
            U46619 0
paths to the root